Customized phage therapies to eradicate
harmful bacteria in chronic diseases
We develop both natural and engineered phage therapies that target harmful bacteria in microbiome-related chronic diseases such as IBD and cancer
Our phage therapy development and target discovery technologies were developed by world-leading scientists from top-tier institutions including MIT and the Weizmann Institute of Science
LEARN ABOUT OUR TECHNOLOGYBiomX’s founders, management and investors all have a long history of excellence that is propelling us to continued success and innovation.
LEARN ABOUT OUR LEADERSHIPOUR INVESTORS
